BrightOwl Loader Loading


I am a versatile business driven people leader. Having worked across much of the pharmaceutical value chain, I thrive in cross functional environments where the focus is on delivering business growth. For me, quick learning and business acumen have been essential in moving between different functions. In my recent roles, I have engaged in all elements of the market work in pharmaceutics including market access, medical affairs, learning and development, commercial strategy, sales execution, commercial excellence, market insights and – although less pronounced – public affairs. I have worked in several different countries/cultures and sat in numerous internal teams thereby developing a firm understanding of international vs. national business perspectives. People refer to me as a person who gets things done, keeps calm under pressure and as a strong and trusted leader. 2014 Head of Dermatology, LEO Pharma Nordic and Country Lead LEO Pharma Norway. 2013 Head of Dermatology, LEO Pharma Scandinavia. 2010 Business Support Director, LEO Pharma UK. Responsible for business planning, performance follow-up, budgeting and special projects such as patent litigation, outlicensing, business and strategy development. Managerial responsibility for business services, procurement, IT, QMS implementation and process optimisation. 2009 Business Controller, LEO Pharma UK. 2006 R&D Project Manager, LEO Pharma A/S. Drug Development and Manufacturing process development projects 2004 R&D Management Executive Assistant at LEO Pharma A/S. 2000- Research-engineer at Leo Pharma A/S, Department of Medicinal Chemistry.


Current Experience

  • Head of Dermatology (Business Unit Director) and Country Lead, LEO Norway
    Since January 2014
    The LEO Pharma Nordic organisation was built for the purpose of reaching new levels of collaboration across the Nordic countries and capitalising on synergies. I am accountable for the dermatological business unit with full PnL responsibilities across the Nordic markets. Furthermore, I serve as the Country Lead for LEO Pharma Norway. Following am optimisation of the Nordic organisation in late 2012, the LEO Nordic Dermatology team has launched a new solution for patients each year since then. A testament to the great ambitions that LEO has for becoming the preferred dermatology care partner and equally a strong testament to this team's ability for executing. We work across a wide range of dermatological diseases including psoriasis, acne, actinic keratosis, atopic dermatitis and skin infections. Whilst the primary part of our business is Rx, we have now started working closer to patients in the cosmetics/OTC field with the Locobase products that LEO recently acquired.

  • Part-owner
    Since March 2006
    Minority owner. My present involvement in the company is as a member of the board. This has added great learning and insights in terms of entrepreneurial work and prioritisation in a small but fast growing company.

Past Experience

  • Head of Dermatology BU, LEO Nordic and Country Lead, LEO NO. Copenhagen, Denmark
    January 2014 --- January 2017

  • Head of Dermatology (Business Unit Director)
    January 2013 --- January 2014
    The business unit was responsible for all sales and marketing activities in the Danish, Swedish and Norweigan markets within LEO Pharma's strategic product disease areas of Actinic Keratoses and Psoriasis as well as the established dermatology brands within Skin Infections, Atopic Dermatitis and Acne. Product launch: LEO Scandinavia launched an exiting product, Picato(r) for the topical treatment of Actinic Keratoses in 2013. This is the first New Molecule Entity in this therapy area for a long time and proved an interesting challenge in terms of market access and how the novelty of this product was perceived by the payer authorities. Following a turbulent period for the company due to staff redundancies, we worked with improving empowerment, change readiness/acceptance and optimisation of working processes. There was also work directed at improving cross functional sharing to build our capacity whilst retaining adaptability and our ability to deliver on our objectives.

  • Director, Business Support
    June 2010 --- January 2013
    In addition to the Business Controlling and Business Process optimisation responsibilities, the role also includes managing the Business Services department and the IT-department. Furthermore, we established a local procurement function within the UK affiliate in close collaboration with the global procurement department. A significant part of the responsibilities in this role were special projects such as product divestment, patent litigation management, site divestment, process optimisation, technology implementation etc.

  • Business Controller
    August 2009 --- June 2010
    - Key liaison point between Finance and the business including budget process, performance review, business planning etc. - Special projects such as patent litigation. - Part of UK Leadership team and extended “Region North Atlantic” Leadership team.

  • R&D Project Manager
    July 2006 --- August 2009
    - Leadership of cross functional project teams - Activity prioritisation and planning across various functions of the company incl. pharmaceutical development, manufacturing, sales and marketing, finance, regulatory affairs, clinical development, non-clinical development, in vivo pharmacology, global project management etc. - Coordination with various steering committees - Assessment of business opportunities within anti-infectives both in terms of new geographies (e.g. China) and new products.

  • R&D Management Executive Assistant
    August 2004 --- May 2006
    I served as a personal assistant to the head of R&D activities (Senior Vice President). The job included tasks such as financial monitoring, interactions with executives on behalf of the SVP, planning R&D management activities, setting up joint meetings etc.


Self Assessment :
AdaptabilityAnalytical thinkingApproachabilityCompetitivenessCommunicativeInnovative thinkingProactivityResiliencySelf-disciplineStrategic thinkingTrustResult OrientedCreative thinking


LinkedIn Assessment :
Clinical DevelopmentPharmaceutical IndustryR&DProject PlanningmanagementBudgetsDrug DevelopmentClinical trialsMarket accessRegulatory affairsSOPBiopharmaceuticalsLifesciencesPharmaceutical salesRegulatory submissionsDrug DiscoverypharmacologyCROCross-functional team leadershipQuality SystemDermatologyLife SciencesProduct launchStrategyBusiness ManagementResearch and Development (R&D)

Skills and Expertise

Self Assessment :
Analytical skillsWritten presentation


  • in from MCE Market Access in 2012
  • Master in Industrial Drug Development from Danmarks Farmaceutiske Universitet in 2008
  • Diploma in Danish Pharmaceutical Academy from Lægemiddelindustriforeningen in 2003
  • Bachelor of Applied Science (B.A.Sc.) in from Danmarks Tekniske Universitet in 2000


BrightOwl Assessment:
Self Assessment:
Full Proficiency
Professional Proficiency
Professional Proficiency
Elementary Proficiency

Work Preferences

  • Notice Period:
    1 week
  • Positions I am interested in:
    General Manager Managing Director Management Consultant R&D Director
  • Locations I am interested in:
    Copenhagen, Denmark Malmö, Sweden Oslo, Norway
  • Work From Home:
    Yes, 2 to 1 days per week
  • Work Regime:
    Permanent position :    50-75% FTE
    BrightOwl freelancer :    35-50 Hours per week :    100% Free Per Month(in coming months)
  • International:

Area / Region

Copenhagen, Denmark


Driving License
  • Yes